MCC950, potently suppressed IL-1β release from PBMCs from patients with severe (stable and exacerbating) and non-severe asthma and healthy subjects that are stimulated with nigericin alone, LPS alone, or LPS + nigericin (Fig. 1A–H). The gene discussed is IL1B; the disease is asthma.